EKF Diagnostics Investor Announcements
EKF Diagnostics Holdings plc is an in-vitro diagnostics (IVD) business. The Company is engaged in the designing, development, manufacture and selling of diagnostic analyzers, reagents and ancillary products. This activity takes place across several geographical locations which include the United Kingdom, United States of America, Germany, Poland and Russia.
Disclosures in accordance with the AIM Rules following the announcement on 8 April 2016 that Christopher Mills had been appointed as Non-Executive Chairman.
EKF Diagnostics announces that it has served notice to redeem the £3 million convertible loan from Zwanziger Family Ventures LLC .
EKF Diagnostics Holdings plc announces its unaudited final results for the year ended 31 December 2015.
EKF Diagnostics Holdings plc (AIM: EKF), the point-of-care business, announces that Ron Zwanziger has resigned as a non-executive director.
EKF Diagnostics Holdings plc announces that Christopher Mills has been appointed as Non-Executive Chairman with immediate effect.
Notice of Investor Results and Presentation.
Newsletter
Keep up to date with all our activities, events, exhibitions, promotions, investor news & more.